XMD-17-51
CAS No. 1628614-50-5
XMD-17-51 ( XMD17-51 )
Catalog No. M23725 CAS No. 1628614-50-5
XMD-17-51 is a potent and highly selective NUAK1 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 873 | In Stock |
|
50MG | 1782 | In Stock |
|
100MG | 2250 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameXMD-17-51
-
NoteResearch use only, not for human use.
-
Brief DescriptionXMD-17-51 is a potent and highly selective NUAK1 inhibitor.
-
DescriptionXMD-17-51 is a potent and highly selective NUAK1 inhibitor.
-
SynonymsXMD17-51
-
PathwayMembrane Transporter/Ion Channel
-
TargetAMPK
-
RecptorNUAK1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1628614-50-5
-
Formula Weight404.5
-
Molecular FormulaC21H24N8O
-
Purity>98% (HPLC)
-
SolubilityDMSO:75 mg/ml (185.43 mM); Ethanol:10 mg/ml (24.72 mM); Water:2 mg/ml (4.94 mM)
-
SMILESO=C1N(C)C2=CN=C(NC3=CN(C4CCNCC4)N=C3)N=C2N(C)C5=CC=CC=C15
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
ETC-1002
A small molecule regulator of lipid and carbohydrate metabolism that targets ACC (acetyl-CoA carboxylase) with IC50 of 29 uM.
-
Gomisin J
Gomisin J is a natural product and have vasodilatory activity.?Gomisin J suppresses lipid accumulation by regulating the expression of lipogenic and lipolytic enzymes and inflammatory molecules through activation of AMPK, LKB1 and Ca2+/calmodulin-dependent protein kinase II and inhibition of fetuin-A in HepG2 cells.
-
Kudinoside D
Kudinoside D exerts anti-adipogenic effects through modulation of adipogenic transcription factors via AMPK signaling pathway.